Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Sep 2011 - Clin. Cancer Res.; 17(17):1078-0432 [PMID:21771874]
[Lesterhuis WJ] [de Vries IJ] [Schreibelt G] [Lambeck AJ] [Aarntzen EH] [Jacobs JF] [Scharenborg NM] [van de Rakt MW] [de Boer AJ] [Croockewit S] [van Rossum MM] [Mus R] [Oyen WJ] [Boerman OC] [Lucas S] [Adema GJ] [Punt CJ] [Figdor CG]

Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
Dez 2010 - Anticancer Res.; 30(12):1791-7530 [PMID:21187495]
[Lesterhuis WJ] [De Vries IJ] [Schreibelt G] [Schuurhuis DH] [Aarntzen EH] [De Boer A] [Scharenborg NM] [Van De Rakt M] [Hesselink EJ] [Figdor CG] [Adema GJ] [Punt CJ]

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Apr 2009 - Clin. Cancer Res.; 15(7):1078-0432 [PMID:19318472]
[Verdijk P] [Aarntzen EH] [Lesterhuis WJ] [Boullart AC] [Kok E] [van Rossum MM] [Strijk S] [Eijckeler F] [Bonenkamp JJ] [Jacobs JF] [Blokx W] [Vankrieken JH] [Joosten I] [Boerman OC] [Oyen WJ] [Adema G] [Punt CJ] [Figdor CG] [de Vries IJ]

Maximizing dendritic cell migration in cancer immunotherapy.
Jun 2008 - Expert Opin Biol Ther; 8(7):1744-7682 [PMID:18549318]
[Verdijk P] [Aarntzen EH] [Punt CJ] [de Vries IJ] [Figdor CG]

Dendritic cell vaccines in melanoma: from promise to proof?
Apr 2008 - Crit. Rev. Oncol. Hematol.; 66(2):1040-8428 [PMID:18262431]
[Lesterhuis WJ] [Aarntzen EH] [De Vries IJ] [Schuurhuis DH] [Figdor CG] [Adema GJ] [Punt CJ]